Labcorp Holdings Inc.
General ticker "LH" information:
- Sector: Health Care
- Industry: Medical - Equipment & Services
- Capitalization: $21.9B (TTM average)
Labcorp Holdings Inc. follows the US Stock Market performance with the rate: 10.3%.
Estimated limits based on current volatility of 1.2%: low 255.07$, high 261.22$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-05-29, amount 0.72$ (Y1.11%)
- Total employees count: 71000 (+1.4%) as of 2025
- US accounted for 83.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Market demand fluctuations, Government funding dependency, Liquidity and credit risks, Operational and conduct risks
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [213.53$, 309.13$]
- 2026-12-31 to 2027-12-31 estimated range: [218.33$, 316.48$]
Financial Metrics affecting the LH estimates:
- Negative: with PPE of 15.4 at the end of fiscal year the price was high
- Positive: 6.59 < Operating cash flow per share per price, % of 7.78
- Positive: 7.54 < Operating profit margin, % of 9.92
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 4.55
- Positive: Inventory ratio change, % of -0.09 <= 0
- Negative: 0.73 < Interest expense per share per price, % of 1.06
- Positive: 42.59 < Shareholder equity ratio, % of 46.87 <= 64.29
- Positive: -14.17 < Investing cash flow per share per price, % of -5.66
- Negative: negative Industry operating cash flow (median)
Short-term LH quotes
Long-term LH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $12,161.60MM | $13,008.90MM | $13,951.70MM |
| Operating Expenses | $11,436.00MM | $11,922.20MM | $12,567.00MM |
| Operating Income | $725.60MM | $1,086.70MM | $1,384.70MM |
| Non-Operating Income | $-156.70MM | $-127.20MM | $-277.20MM |
| Interest Expense | $199.60MM | $208.30MM | $224.10MM |
| Income(Loss) | $568.90MM | $959.50MM | $1,107.50MM |
| Taxes | $188.50MM | $212.40MM | $229.80MM |
| Other Income(Loss) | $38.80MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $418.00MM | $746.00MM | $876.50MM |
| Stockholders Equity | $7,875.00MM | $8,052.20MM | $8,619.80MM |
| Inventory | $474.60MM | $493.20MM | $534.70MM |
| Assets | $16,725.10MM | $18,379.00MM | $18,392.70MM |
| Operating Cash Flow | $1,327.70MM | $1,585.80MM | $1,640.50MM |
| Capital expenditure | $453.60MM | $489.90MM | $434.50MM |
| Investing Cash Flow | $-1,171.50MM | $-1,366.80MM | $-1,194.00MM |
| Financing Cash Flow | $-59.30MM | $779.90MM | $-1,457.00MM |
| Earnings Per Share** | $4.80 | $8.89 | $10.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.